Top 5 News: 1/9-1/15
1) Reports of GE’s move follow years of local expansion of its life sciences business – BBJ, 1/13/2016
News that GE is moving its headquarters to the state comes a year and a half after the company moved the headquarters for its life sciences business to Marlborough.
2) Key takeaways from the Shire-Baxalta deal — and the state’s new largest drugmaker – BBJ, 1/11/2016
With the planned acquisition announced this morning of two drugmakers both with a major presence in the Bay State, Shire Pharmaceuticals could soon be the state’s biggest drugmaker, eclipsing Biogen in employees and very possibly in both revenue and market value.
3) Drug trailblazers Moderna, Juno grab forum’s spotlight – Boston Globe, 1/15/2016
New ways to fight diseases are guaranteed to get plenty of attention at the top gathering of health care entrepreneurs and investors. So it’s no surprise that Moderna Therapeutics Inc. and Juno Therapeutics Inc., pioneers in potentially game-changing drug discovery technologies, emerged as two of the highest profile companies at this week’s J.P. Morgan Healthcare Conference.
4) State opens annual tax program for life science firms that create jobs – BBJ, 1/14/2016
In a good sign for continued funding of the Massachusetts Life Sciences Center, the state agency today announced it’s taking applications for the annual tax incentive program which rewards companies for creating jobs.
5) NIH pumps $260m into search for disease genes that matter – STAT, 1/14/2016
Federal science officials on Thursday announced the launch of a $260 million program to identify rare gene variants that raise or lower people’s risk of developing such common conditions as heart disease, stroke, diabetes, and autism — the latest Big Science effort to mine DNA sequences for medical breakthroughs.